Healthcare provider profile · identity verified

Gregory George Sehring, MD

Family Practice · WAUKESHA, WI · NPI 1346421112

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	429	111
Lisinopril	Lisinopril	226	59
Amlodipine Besylate	Amlodipine Besylate	209	54
Omeprazole	Omeprazole	206	44
Levothyroxine Sodium	Levothyroxine Sodium	202	44
Losartan Potassium	Losartan Potassium	153	41
Metformin Hcl Er	Metformin Hcl	135	38
Tamsulosin Hcl	Tamsulosin Hcl	121	26
Hydrochlorothiazide	Hydrochlorothiazide	117	32
Metoprolol Succinate	Metoprolol Succinate	112	28
Rosuvastatin Calcium	Rosuvastatin Calcium	109	32
Pantoprazole Sodium	Pantoprazole Sodium	98	19
Simvastatin	Simvastatin	91	21
Gabapentin	Gabapentin	80	18
Metformin Hcl	Metformin Hcl	80	19
Albuterol Sulfate Hfa	Albuterol Sulfate	70	23
Ozempic	Semaglutide	68	16
Fluticasone Propionate	Fluticasone Propionate	65	18
Duloxetine Hcl	Duloxetine Hcl	60	12
Sertraline Hcl	Sertraline Hcl	55	11
Trazodone Hcl	Trazodone Hcl	54	14
Fluoxetine Hcl	Fluoxetine Hcl	50	11
Potassium Chloride	Potassium Chloride	48	11
Amitriptyline Hcl	Amitriptyline Hcl	43	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	42	suppressed
Clopidogrel	Clopidogrel Bisulfate	41	12
Alprazolam	Alprazolam	39	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	38	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	37	suppressed
Ezetimibe	Ezetimibe	36	suppressed
Montelukast Sodium	Montelukast Sodium	36	suppressed
Glipizide	Glipizide	35	suppressed
Allopurinol	Allopurinol	34	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	34	suppressed
Nifedipine Er	Nifedipine	34	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	33	suppressed
Carvedilol	Carvedilol	31	11
Ipratropium Bromide	Ipratropium Bromide	29	suppressed
Januvia	Sitagliptin Phosphate	29	suppressed
Spironolactone	Spironolactone	28	13
Glimepiride	Glimepiride	27	suppressed
Pravastatin Sodium	Pravastatin Sodium	26	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	24	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	23	17
Trulicity	Dulaglutide	23	suppressed
Atenolol	Atenolol	22	suppressed
Furosemide	Furosemide	22	suppressed
Paroxetine Hcl	Paroxetine Hcl	22	suppressed
Alendronate Sodium	Alendronate Sodium	21	suppressed
Lorazepam	Lorazepam	21	suppressed
Symbicort	Budesonide/Formoterol Fumarate	21	suppressed
Benazepril Hcl	Benazepril Hcl	20	suppressed
Xarelto	Rivaroxaban	20	suppressed
Meloxicam	Meloxicam	19	suppressed
Celecoxib	Celecoxib	18	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	18	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	18	suppressed
Gemfibrozil	Gemfibrozil	17	suppressed
Bupropion Xl	Bupropion Hcl	16	suppressed
Clonazepam	Clonazepam	16	suppressed
Eliquis	Apixaban	16	suppressed
Ventolin Hfa	Albuterol Sulfate	16	suppressed
Fluconazole	Fluconazole	15	suppressed
Lamotrigine	Lamotrigine	15	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	15	suppressed
Clonidine	Clonidine	14	suppressed
Fenofibrate	Fenofibrate	14	suppressed
Jardiance	Empagliflozin	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	14	suppressed
Baclofen	Baclofen	13	suppressed
Citalopram Hbr	Citalopram Hydrobromide	13	suppressed
Clotrimazole	Clotrimazole	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Famotidine	Famotidine	13	suppressed
Qvar Redihaler	Beclomethasone Dipropionate	13	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	13	suppressed
Valsartan	Valsartan	13	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Zenpep	Lipase/Protease/Amylase	12	suppressed
Acetazolamide	Acetazolamide	11	suppressed
Diazepam	Diazepam	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Levetiracetam	Levetiracetam	11	suppressed
Memantine Hcl Er	Memantine Hcl	11	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error